Increased periventricular thalamic damage gradient in multiple sclerosis detected by quantitative gradient echo MRI

Amjad Samara1, Biao Xiang1, Bradley Judge2

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, St. Louis, MO 63110, USA.

Abstract

Insights

Multiple sclerosis (MS) shows a steeper thalamic tissue integrity gradient from the ventricle, linked to disease duration and disability. This supports a surface-in pathology, potentially CSF-mediated.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomedical Engineering

Background:

  • Multiple sclerosis (MS) involves thalamic tissue damage, often exhibiting a 'surface-in' gradient from the ventricular surface.
  • The clinical implications of this thalamic gradient in MS remain incompletely understood.

Purpose of the Study:

  • To evaluate the periventricular thalamic gradient of tissue integrity in MS using quantitative gradient-recalled echo (qGRE) MRI.
  • To investigate the relationship between this gradient and clinical variables in MS patients.

Main Methods:

  • Acquired structural and qGRE MRI scans from MS patients and healthy controls (HC).
  • Utilized qGRE-derived R2t* values as a measure of tissue integrity.
  • Calculated the periventricular thalamic gradient by analyzing R2t* values in concentric bands radiating from the ventricular surface.

Main Results:

  • MS patients exhibited a significantly steeper periventricular thalamic gradient compared to HC (mean slope 0.55 vs. 0.36; p < 0.001).
  • The MS thalamic gradient correlated with longer disease duration (p = 0.027) and higher Expanded Disability Status Scale (EDSS) scores (p = 0.019).
  • Thalamic involvement was symmetrical in both left and right hemispheres.

Conclusions:

  • An increased thalamic gradient in MS was detected in vivo using qGRE MRI.
  • This gradient is associated with disease duration and clinical disability, supporting the 'surface-in' pathology hypothesis in MS.
  • The symmetric thalamic involvement suggests a potential cerebrospinal fluid (CSF)-mediated pathological process.